Advertisement
Screener

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Reviva Pharmaceuticals Holdings, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Reviva Pharmaceuticals Holdings, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $24.59M went out.
  • Fiscal year ended 2025-12-31: from financing, $25.56M came in.
  • Fiscal year ended 2025-12-31: change in cash, $962.46K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$24.59M$25.56M*$962.46K
2024-12-31-$33.54M$23.65M*-$9.89M
2023-12-31-$28.32M$33.17M*$4.85M
2022-12-31-$18.96M$7.79M*-$11.17M
2021-12-31-$10.67M$31.50M$20.93M
2020-12-31-$4.07M$0.00$12.83M*$8.76M
2020-02-29-$426.59K$5.70M-$6.27M$750.00K*-$243.77K
2019-12-31-$218.44K-$118.44K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$2.12M*
2026-03-31-$3.80M$11.55M*$7.75M
2025-12-31-$5.80M*$7.05M*
2025-09-30-$5.59M*$8.41M*
2025-06-30-$5.01M*$10.09M*
2025-03-31-$8.19M-$8.19M
2024-12-31-$9.10M*$17.02M*
2024-09-30-$4.24M*$3.62M*
2024-06-30-$8.48M*$2.68M*
2024-03-31-$11.73M-$11.39M
2023-12-31-$8.88M*$27.27M*
2023-09-30-$6.18M*
2023-06-30-$5.32M*$5.21M*
2023-03-31-$7.95M$687.09K*-$7.26M
2022-12-31-$4.69M*
2022-09-30-$4.00M*$7.77M*
2022-06-30-$4.00M*
2022-03-31-$6.27M-$6.27M
2021-12-31-$3.90M*
2021-09-30-$2.31M*
2021-06-30-$1.34M*$31.50M*
2021-03-31-$3.12M-$3.12M
2020-12-31-$2.94M*$11.34M*
2020-11-30-$213.69K*-$206.12K*-$109.13K*
2020-09-30-$715.64K*$874.10K*
2020-08-31-$271.61K*-$210.84K*$0.00*
2020-06-30-$354.73K*
2020-05-31-$35.46K$26.77M-$26.98M$128.71K
2020-03-31-$60.66K$169.34K
2020-02-29-$247.85K*$5.70M*-$6.27M*$750.00K*
2019-11-30-$76.93K*$0.00*$0.00*$0.00*
2019-08-31-$62.45K*$0.00*$0.00*
2019-05-31-$39.36K$0.00$0.00-$39.36K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06